Published in Clin Rheumatol on December 09, 2006
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol (2012) 1.32
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06
The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications. Rheumatol Int (2009) 0.90
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study. Rheumatology (Oxford) (2016) 0.75
A portable dermatoscope for easy, rapid examination of periungual nailfold capillary changes in patients with systemic sclerosis. Rheumatol Int (2010) 0.75
Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon. Clin Rheumatol (2015) 0.75
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1980) 21.86
Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol (2000) 2.61
Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. J Clin Epidemiol (2000) 2.56
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum (1980) 2.13
Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum (2001) 1.92
Wide-field capillary microscopy. Arthritis Rheum (1981) 1.67
The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol (2003) 1.60
Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy. Arthritis Rheum (1973) 1.30
Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol (1983) 1.27
Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med (1976) 1.26
Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol (1985) 1.25
Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. J Rheumatol (1982) 1.20
Microvasculature in systemic sclerosis. Rheum Dis Clin North Am (1990) 1.01
Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis (2001) 0.92
Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. Arthritis Rheum (1981) 0.90
The poor man's capillary microscope. A novel technique for the assessment of capillary morphology. Ann Rheum Dis (1997) 0.88
The kappa statistic in rehabilitation research: an examination. Arch Phys Med Rehabil (2004) 0.87
Nailfold capillary abnormalities. Clin Rheum Dis (1982) 0.86
"Wide-field" photography of nailfold capillary bed and a scale of plexus visualization scores (PVS). Microvasc Res (1970) 0.82
Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch Dermatol (1992) 0.81
Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med (1984) 0.80
Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clin Exp Rheumatol (1999) 0.80
Office nail fold capillary microscopy using ophthalmoscope. J Am Acad Dermatol (1982) 0.77
Variations in the skin microvascular patterns of the hand. Bibl Anat (1977) 0.76
In vivo capillary microscopy findings and ophthalmoscopy findings in scleroderma. Arthritis Rheum (1987) 0.76
Abnormal capillary patterns and systemic disease in scleroderma (progressive systemic sclerosis). Bibl Anat (1975) 0.75
Nalifold capillary microscopy made easy. Arthritis Rheum (1977) 0.75
In vivo capillary microscopy for the clinician. Arthritis Rheum (1978) 0.75
A new capillaroscopic assessment of microvascular damage vs Maricq classification in patients with isolated Raynaud phenomenon. Int Angiol (1990) 0.75
Capillary morphology and the course of illness in schizophrenic patients. J Nerv Ment Dis (1966) 0.75
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol (2007) 4.36
Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol (2008) 3.43
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma (2003) 2.90
Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo-controlled trial. Arthritis Rheum (2003) 2.21
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol (2006) 2.17
Utility of the Patient Health Questionnaire-9 to assess suicide risk in patients with systemic sclerosis. Arthritis Care Res (Hoboken) (2013) 2.14
Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheumatol (2014) 1.99
Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum (2006) 1.99
Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum (2004) 1.87
Therapeutic exercise for people with osteoarthritis of the hip or knee. A systematic review. J Rheumatol (2002) 1.79
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J (2012) 1.62
Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum (2007) 1.61
Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum (2011) 1.55
Resident evaluations: the use of daily evaluation forms in rheumatology ambulatory care. J Rheumatol (2009) 1.52
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review. Rheumatology (Oxford) (2010) 1.49
Exploring mentorship as a strategy to build capacity for knowledge translation research and practice: protocol for a qualitative study. Implement Sci (2009) 1.48
Frequency of adverse drug reactions in patients with systemic lupus erythematosus. J Rheumatol (2003) 1.48
A new toolkit for conducting clinical trials in rare disorders. J Popul Ther Clin Pharmacol (2014) 1.47
Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis. J Rheumatol (2009) 1.46
Systemic sclerosis - continuing progress in developing clinical measures of response. J Rheumatol (2007) 1.46
Implementation of dietitian recommendations for enteral nutrition results in improved outcomes. J Am Diet Assoc (2006) 1.40
A randomized trial of oral misoprostol in premenopausal women before hysteroscopy. J Obstet Gynaecol Can (2007) 1.40
Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestations. J Rheumatol (2013) 1.39
Nutrition support at the end of life: opinions of Louisiana dietitians. J Am Diet Assoc (2002) 1.38
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study. Rheumatology (Oxford) (2012) 1.31
Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis Rheum (2008) 1.23
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer (2005) 1.21
Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective. Arthritis Care Res (Hoboken) (2011) 1.19
The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis. Arthritis Rheum (2008) 1.18
Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum (2009) 1.18
The development of systemic sclerosis classification criteria. Clin Rheumatol (2007) 1.17
Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med (2010) 1.16
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) (2010) 1.15
Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) (2010) 1.15
Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum (2007) 1.15
Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference. Can J Cardiol (2011) 1.12
Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol (2009) 1.12
Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 1.10
Upper abdominal teratomas in infants: radiological findings and importance of the vascular anatomy. Pediatr Radiol (2008) 1.08
Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol (2007) 1.08
Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides. J Rheumatol (2014) 1.07
Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. Arthritis Rheum (2008) 1.07
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04
Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther (2012) 1.04
Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum (2008) 1.03
Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda. Arthritis Care Res (Hoboken) (2010) 1.03
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res Ther (2008) 1.03
Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology (Oxford) (2009) 1.03
Corticosteroids and the risk of scleroderma renal crisis: a systematic review. Rheumatol Int (2010) 1.03
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum (2009) 1.03
2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Arthritis Care Res (Hoboken) (2015) 1.02
Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren's syndrome. Can J Ophthalmol (2004) 1.02
Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis. J Rheumatol (2009) 1.02
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. Mod Pathol (2006) 1.01
Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. J Rheumatol (2005) 1.01
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update. Can J Cardiol (2013) 1.01
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis. Arthritis Res Ther (2012) 1.01
The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. J Rheumatol (2009) 1.00
Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol (2009) 0.98
Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum (2011) 0.97
The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review. J Rheumatol (2013) 0.97
Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum (2009) 0.96
Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) (2010) 0.96
Exploring mentorship as a strategy to build capacity for knowledge translation research and practice: a scoping systematic review. Implement Sci (2014) 0.96
A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit (2011) 0.95
VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy. Cancer (2005) 0.95
The cost of systemic sclerosis. Arthritis Rheum (2009) 0.94
Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine (2007) 0.94
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN). Clin Exp Rheumatol (2012) 0.94
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken) (2012) 0.94
Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum (2009) 0.94
Discordance between patient and physician assessments of disease severity in systemic sclerosis. J Rheumatol (2010) 0.93
Differences in autoantibody profiles and disease activity and damage scores between childhood- and adult-onset systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum (2012) 0.93
Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum (2012) 0.93
Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts. Semin Arthritis Rheum (2012) 0.93
Biologic therapy for systemic sclerosis: a systematic review. J Rheumatol (2010) 0.93
All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford) (2013) 0.93
Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol (2005) 0.92
A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated water. J Clin Epidemiol (2006) 0.91